Aim Bulletin
PetroTal issues $100m senior bond
PetroTal announced the issue of the $100m senior secured bonds on Wednesday, having initially announced the bonds on 2 February.
DeepVerge upbeat on progress at Modern Water
Environmental and life sciences artificial intelligence company DeepVerge said on Wednesday that, since the offer for the acquisition of Modern Water was completed on 17 November, contractual obligations had been signed for the production of water contamination equipment worth $5m (£3. 6m) to meet its obligations with distributors and customers.
PetroNeft agrees new $2.9m loan facility
Russia-focussed oil and gas exploration and production company PetroNeft announced a new $2. 9m convertible loan facility on Wednesday, providing greater headroom for it to develop value.
Evgen makes progress with recruitment in 'STAR' trial
Clinical stage drug development company Evgen Pharma said on Wednesday that a total of 102 patients had been recruited and randomised to the ‘STAR’, or ‘SFX-01 Treatment for Acute Respiratory infections’, trial.
Transense Technologies swings to profit in first half
Sensor systems developer Transense Technologies reported a threefold improvement in revenue from continuing operations in its first half on Wednesday, to £0. 9m.
Pebble Beach cuts costs as pandemic impacts revenue
Broadcast and streaming automation and content management technology company Pebble Beach said on Wednesday that it expected to report results for 2020 with revenue of around £8. 4m, down from £11. 2m, and adjusted EBITDA of £2. 6m, falling from £3. 8m.
Covid lockdowns impact Gattaca in first half
Engineering and technology recruitment specialist Gattaca updated the market on its first half on Wednesday, saying it was expecting net fee income of £21. 1m, down from £31. 8m year-on-year.
Silence Therapeutics begins dosing in lipoprotein treatment trial
Silence Therapeutics has started dosing subjects in the ‘APOLLO’ phase 1 clinical study of its wholly-owned lead product candidate ‘SLN360’, it announced on Wednesday, for the treatment of elevated lipoprotein-a (Lp(a)) levels.
Marlowe trading strongly as it sets out new goals
Business software and services company Marlowe said on Tuesday that trading in its second half remained “strong”, with results for the year ending 31 March expected to be at the top end of current market expectations.
Creo Medical ends year 'marginally ahead' of forecasts
Medical devices company Creo Medical Group said on Wednesday that trading for 2020 was “marginally ahead” of management expectations, with revenue rising to more than £9m, from £0. 01m in 2019.
ECSC secures two 'significant contract wins'
Cybersecurity services provider ECSC Group said on Wednesday that it had secured two "significant contract wins" in its managed detection and response division with an unnamed "major" UK charity and a mystery leisure group.
Synectics wins new contracts with Ireland's National Transport Authority
Security and surveillance systems group Synectics said on Wednesday that it has recently been awarded several new contracts for the Irish Republic's National Transport Authority.
Ceres Power trades well through end of 2020
Fuel cell technology company Ceres Power updated the market on its trading on Wednesday, reporting that revenue and other operating income for the 18 months ended 31 December would be above market expectations at around £32m to £33m.